Narrow therapeutic range drugs
Executive Summary
Maryland removes six narrow therapeutic range drugs from its formulary of equivalent drug products, effective Dec. 27. The products, all in solid oral dosage forms, are carbamazepine, phenytoin sodium extended, primidone, valproic acid, theophylline extended release and warfarin sodium.